BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18159634)

  • 41. Selective immortalization of tumor-specific T cells to establish long-term T-cell lines maintaining primary cell characteristics.
    Barsov EV
    Methods Mol Biol; 2009; 511():143-58. PubMed ID: 19347296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.
    Davis JW; Nakanishi H; Kumar VS; Bhadkamkar VA; McCormack R; Fritsche HA; Handy B; Gornet T; Babaian RJ
    J Urol; 2008 Jun; 179(6):2187-91; discussion 2191. PubMed ID: 18423725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
    Budd GT
    Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2009 Mar; 181(3):1091-7. PubMed ID: 19150091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
    Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
    Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
    Hanisch E; Hottenrott C; Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
    [No Abstract]   [Full Text] [Related]  

  • 47. Boronate-containing polymer brushes: characterization, interaction with saccharides and mammalian cancer cells.
    Ivanov AE; Eccles J; Panahi HA; Kumar A; Kuzimenkova MV; Nilsson L; Bergenståhl B; Long N; Phillips GJ; Mikhalovsky SV; Galaev IY; Mattiasson B
    J Biomed Mater Res A; 2009 Jan; 88(1):213-25. PubMed ID: 18286619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dielectric cell separation of fine needle aspirates from tumor xenografts.
    Cristofanilli M; Krishnamurthy S; Das CM; Reuben JM; Spohn W; Noshari J; Becker F; Gascoyne PR
    J Sep Sci; 2008 Dec; 31(21):3732-9. PubMed ID: 18958846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring cellulase activity: application of the filter paper assay to low-activity enzyme preparations.
    Nordmark TS; Bakalinsky A; Penner MH
    Appl Biochem Biotechnol; 2007 Apr; 137-140(1-12):131-9. PubMed ID: 18478382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic implications of circulating tumor cells in patients with breast cancer.
    Smerage JB; Hayes DF
    Cancer Invest; 2008 Mar; 26(2):109-14. PubMed ID: 18259939
    [No Abstract]   [Full Text] [Related]  

  • 52. Circulating tumor cells in colorectal cancer: detection methods and clinical significance.
    Tsouma A; Aggeli C; Pissimissis N; Lembessis P; Zografos GN; Koutsilieris M
    Anticancer Res; 2008; 28(6B):3945-60. PubMed ID: 19192655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Filter paper degrading ability of a Trichoderma strain with multinucleate conidia.
    Toyama H; Yano M; Hotta T; Toyama N
    Appl Biochem Biotechnol; 2007 Apr; 137-140(1-12):155-60. PubMed ID: 18478384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating tumor cells in breast cancer: fiction or reality?
    Cristofanilli M; Reuben J; Uhr J
    J Clin Oncol; 2008 Jul; 26(21):3656-7; author reply 3657-8. PubMed ID: 18640950
    [No Abstract]   [Full Text] [Related]  

  • 56. The significance of circulating tumor cells as prognostic markers for colon cancer.
    Meropol NJ
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):247-8. PubMed ID: 19521326
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased perimeter red cell concentration in filter paper bloodspot samples is consistent with constant-load size exclusion chromatography occurring during application.
    Stickle DF; Rawlinson NJ; Landmark JD
    Clin Chim Acta; 2009 Mar; 401(1-2):42-5. PubMed ID: 19049802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
    Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of matrix filtration of low-quality boar semen doses on sperm quality.
    Bussalleu E; Pinart E; Rivera MM; Briz M; Sancho S; Yeste M; Casas I; Fàbrega A; Rigau T; Rodriguez-Gil JE; Bonet S
    Reprod Domest Anim; 2009 Jun; 44(3):499-503. PubMed ID: 19192214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Care plans: Déjà vu all over again.
    McCabe M
    Oncology (Williston Park); 2009 Jul; 23(8 Suppl):10. PubMed ID: 19860036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.